0 NYSE Companies - October 2, 2024Globus Medical Launches the Next Wave of Orthopedic Trauma SolutionsAUDUBON, Pa., Oct. 02, 2024 (GLOBE NEWSWIRE) — Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, announces the […]Read More
0 NYSE Companies - October 2, 2024O-I Glass Announces Third Quarter 2024 Earnings Conference Call and WebcastPERRYSBURG, Ohio , Oct. 02, 2024 (GLOBE NEWSWIRE) — O-I Glass, Inc. (NYSE: OI) has scheduled its third quarter 2024 […]Read More
0 NYSE Companies - October 2, 2024Range Announces Conference Call to Discuss Third Quarter 2024 Financial ResultsFORT WORTH, Texas, Oct. 02, 2024 (GLOBE NEWSWIRE) — RANGE RESOURCES CORPORATION (NYSE: RRC) announced today that its third quarter […]Read More
0 NYSE Companies - October 2, 2024XPO Schedules Third Quarter 2024 Earnings Conference Call for Wednesday, October 30, 2024GREENWICH, Conn., Oct. 02, 2024 (GLOBE NEWSWIRE) — XPO (NYSE: XPO) will hold its third quarter conference call and webcast […]Read More
0 TSX News - October 2, 2024BriaCell Therapeutics Announces Closing of $5 Million OfferingPHILADELPHIA and VANCOUVER, British Columbia, Oct. 02, 2024 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” […]Read More
0 NASDAQ Companies - October 2, 2024QCR Holdings, Inc. to Report Third Quarter 2024 Financial ResultsMOLINE, Ill., Oct. 02, 2024 (GLOBE NEWSWIRE) — QCR Holdings, Inc. (NASDAQ: QCRH) (“QCRH” or the “Company”) announced today that its […]Read More
0 NASDAQ Companies - October 2, 2024Codexis Increases Cash Reserves and Enhances Management Team to Fuel Growth of CompanyCompany raises $31 million through ATM, bringing cash runway into 2027 New additions to leadership in technical operations, finance and […]Read More
0 NASDAQ Companies - October 2, 2024Option Care Health to Announce Third Quarter 2024 Financial Results and Host Conference CallBANNOCKBURN, Ill., Oct. 02, 2024 (GLOBE NEWSWIRE) — Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest […]Read More
0 NASDAQ Companies - October 2, 2024Processa Pharmaceuticals Announces First Patient Dosed in Phase 2 Clinical Trial of NGC-Cap in Metastatic Breast CancerPhase 2 trial is an adaptive designed randomized study comparing NGC-Cap to monotherapy capecitabine Results from this Phase 2 trial […]Read More
0 NASDAQ Companies - October 2, 2024Venus Concept to Release Third Quarter of Fiscal Year 2024 Financial Results on November 13, 2024TORONTO, Oct. 02, 2024 (GLOBE NEWSWIRE) — Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical […]Read More